Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v1-EN
Language English English
Date Updated 2019-06-12 2019-06-11
Drug Identification Number 02441527 02441527
Brand name PANTOPRAZOLE SODIUM FOR INJECTION PANTOPRAZOLE SODIUM FOR INJECTION
Common or Proper name Pantoprazole for Injection Pantoprazole for Injection
Company Name GENERIC MEDICAL PARTNERS INC GENERIC MEDICAL PARTNERS INC
Ingredients PANTOPRAZOLE PANTOPRAZOLE
Strength(s) 40MG 40MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 Vial 1 Vial
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-06-11 2019-06-11
Actual start date 2019-06-11 2019-06-11
Estimated end date 2019-08-30 2019-08-30
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments GMP will supply existing contracted business until otherwise stated. GMP will supply existing contracted business until otherwise stated.
Health Canada comments